<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">REMEDIUM</journal-id><journal-title-group><journal-title>REMEDIUM</journal-title></journal-title-group><issn publication-format="print">1561-5936</issn><issn publication-format="electronic">2658-3534</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1270</article-id><article-id pub-id-type="doi">10.21518/1561-5936-2018-5-64-68</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Pharmaceutical industry for Q I, 2018</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Romanova</surname><given-names>Svetlana</given-names></name><bio></bio><email>noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff id="aff-1">Remedium</aff><pub-date date-type="epub" iso-8601-date="2018-12-06" publication-format="electronic"><day>06</day><month>12</month><year>2018</year></pub-date><issue>6</issue><fpage>64</fpage><lpage>68</lpage><history><pub-date date-type="received" iso-8601-date="2022-03-18"><day>18</day><month>03</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2018,</copyright-statement><copyright-year>2018</copyright-year></permissions><abstract>The analysis of pharmaceutical enterprises is performed using the data of the state statistical reporting of the industry enterprises. According to Rosstat, the physical volume index stratified by type of economic activity with code 21 «Production of medicinal products and materials used for medical purposes» for the first quarter was estimated at the level of 110.7% compared to the corresponding period of the previous year.</abstract><kwd-group xml:lang="en"><kwd>pharmaceutical industry</kwd><kwd>medical industry</kwd><kwd>medical products</kwd><kwd>drugs</kwd><kwd>pharmacothera-peutic groups</kwd><kwd>pharmaceutical substances</kwd><kwd>analysis</kwd><kwd>release indicators</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>фармацевтическая промышленность</kwd><kwd>медицинская промышленность</kwd><kwd>медицинская продукция</kwd><kwd>лекарственные средства</kwd><kwd>фармакотерапевтические группы</kwd><kwd>фармацевтические субстанции</kwd><kwd>анализ</kwd><kwd>показатели выпуска</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Королев М.А., Фигурнов Э.Б. Статистика и экономический анализ в управлении народным хозяйством. М.: «Экономика», 1985.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Романова С.А. Фармацевтическая промышленность за I квартал 2017 г. Ремедиум, 2017, 6: 48-52.</mixed-citation></ref></ref-list></back></article>
